ALGS

7.65

2.89% 0.215

Handel nachbörslich: 7.49 -0.16 -2.09%

Aligos Therapeutics Inc (ALGS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ALGS? Forum Prognose

Schlusskurs vom Vortag:

$7.435

Offen:

$7.57

24-Stunden-Volumen:

57,864

Relative Volume:

0.52

Marktkapitalisierung:

$40.94M

Einnahmen:

$7.97M

Nettoeinkommen (Verlust:

$-75.74M

KGV:

-0.315

EPS:

-24.2853

Netto-Cashflow:

$-85.33M

1W Leistung:

-4.85%

1M Leistung:

-8.49%

6M Leistung:

-63.59%

1J Leistung:

-43.23%

1-Tages-Spanne:

$7.3049

$7.765

1-Wochen-Bereich:

$7.09

$8.49

52-Wochen-Spanne:

$3.76

$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Firmenname

Aligos Therapeutics Inc

Sektor

Healthcare (1161)

Branche

Biotechnology (646)

Telefon

(800) 466-6059

Adresse

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

ALGS's Discussions on Twitter

Vergleichen Sie ALGS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ALGS Aligos Therapeutics Inc	7.65	52.62M	7.97M	-75.74M	-85.33M	-24.29
VRTX Vertex Pharmaceuticals Inc	395.92	96.01B	11.42B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	561.55	57.86B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	432.52	57.02B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	646.60	39.10B	3.05B	1.28B	-614.78M	19.58
ONC Beone Medicines Ltd Adr	307.51	34.45B	3.81B	-644.79M	-669.77M	-6.24

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-19	Eingeleitet	H.C. Wainwright	Buy
2023-01-06	Hochstufung	Jefferies	Hold → Buy
2023-01-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-03-23	Herabstufung	Piper Sandler	Overweight → Neutral
2022-01-07	Herabstufung	JP Morgan	Overweight → Neutral
2022-01-06	Herabstufung	Jefferies	Buy → Hold
2021-09-09	Eingeleitet	SVB Leerink	Outperform
2021-05-17	Fortgesetzt	Piper Sandler	Overweight
2020-11-10	Eingeleitet	Cantor Fitzgerald	Overweight
2020-11-10	Eingeleitet	JP Morgan	Overweight
2020-11-10	Eingeleitet	Jefferies	Buy
2020-11-10	Eingeleitet	Piper Sandler	Overweight

Alle ansehen

Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten

09:16 AM

How to monitor Aligos Therapeutics Inc. with trend dashboardsJuly 2025 Action & Pattern Based Trade Signal System - Newser

09:16 AM

08:46 AM

Aligos begins dosing in phase 2 HBV drug study By Investing.com - Investing.com Australia

08:46 AM

Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection - The Manila Times

08:46 AM

08:44 AM

Aligos begins dosing in phase 2 HBV drug study - Investing.com

08:44 AM

08:30 AM

Aligos Begins Major Phase 2 Study Testing Potential Best-in-Class Hepatitis B Drug - Stock Titan

08:30 AM

07:36 AM

Aligos Therapeutics Inc. stock outlook for YEARJuly 2025 PreEarnings & Long-Term Capital Growth Strategies - Newser

07:36 AM

03:27 AM

Best data tools to analyze Aligos Therapeutics Inc. stockJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - Newser

03:27 AM

01:49 AM

Does Aligos Therapeutics Inc. show high probability of reboundQuarterly Trade Summary & Real-Time Volume Surge Alerts - Newser

01:49 AM

12:24 PM

Volatility clustering patterns for Aligos Therapeutics Inc. [July 2025 EndofMonth]Free Weekly High Return Stock Opportunities - Newser

12:24 PM

Aug 12, 2025

Smart tools for monitoring Aligos Therapeutics Inc.’s price actionShort Term Momentum Based Trading Strategy - Newser

Aug 12, 2025

Is it too late to sell Aligos Therapeutics Inc.Weekly Market Summary & Stock Market Timing Techniques - Newser

Aug 12, 2025

Why Aligos Therapeutics Inc. stock attracts strong analyst attentionLow Drawdown Stock Screener with Analysis - Newser

Aug 12, 2025

How Efficient Is Aligos Therapeutics Inc. at Controlling Operating CostsConservative Equity Setup with Signal Analysis - Newser

Aug 12, 2025

Will Aligos Therapeutics Inc. price bounce be sustainableFree Low Capital High Return Stock Plans - Newser

Aug 12, 2025

Can ALGS sustain its earnings growth beyond 2024? - AInvest

Aug 12, 2025

What's behind ALGS' volatile quarterly earnings? - AInvest

Aug 12, 2025

Aug 11, 2025

Ranking Aligos Therapeutics Inc. among high performing stocks via toolsFree AI-Powered Trade Planning with Indicators - Newser

Aug 11, 2025

Moving Average Trends for Aligos Therapeutics Inc. Stock: What They IndicateRisk Adjusted Trade Signal Screening Tool - Newser

Aug 11, 2025

Can Aligos Therapeutics Inc. rally from current levelsFree Access to Real-Time Trade Insights - Newser

Aug 11, 2025

Using Bollinger Bands to evaluate Aligos Therapeutics Inc.Weekly High Conviction Trade Setup Analysis - Newser

Aug 11, 2025

Aug 10, 2025

What indicators show strength in Aligos Therapeutics Inc.Intraday Price Forecast Using Volume Models - Newser

Aug 10, 2025

News impact scoring models applied to Aligos Therapeutics Inc.Proven Trading System with Consistent Gains - Newser

Aug 10, 2025

Aug 09, 2025

Aligos Therapeutics Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 09, 2025

Custom watchlist performance reports with Aligos Therapeutics Inc.Free Entry Alert Based on Volume Spikes - Newser

Aug 09, 2025

What explains ALGS' consistent earnings surprises? - AInvest

Aug 09, 2025

Will Aligos Therapeutics Inc. stock go up soonExpert-Backed High Yield Stock Watchlist - Newser

Aug 09, 2025

Is Aligos Therapeutics Inc. showing signs of accumulationConsistent Gain Plan with AI Support - Newser

Aug 09, 2025

Volatility clustering patterns for Aligos Therapeutics Inc.Free Proven Entry Plan With Low Risk Trade - Newser

Aug 09, 2025

Aug 08, 2025

Aligos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025